Evexia Lifecare Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

Stock Price Movement and Market Context

On 27 Feb 2026, Evexia Lifecare’s shares closed at Rs.1.48, down 3.23% on the day, underperforming its sector by 3.56%. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. This new low contrasts sharply with its 52-week high of Rs.3.04, indicating a decline of over 51% from the peak.

The broader market environment also reflected weakness, with the Nifty index closing at 25,178.65, down 317.9 points or 1.25%. The Nifty remains 4.74% below its own 52-week high of 26,373.20. While the index trades below its 50-day moving average, the 50DMA remains above the 200DMA, suggesting mixed signals for the broader market. Large-cap segments dragged the market lower, with the Nifty Next 50 index falling 1.3%.

Financial Performance and Valuation Metrics

Evexia Lifecare’s financial indicators reveal challenges that have contributed to the stock’s decline. Over the past year, the stock has delivered a negative return of 42.97%, starkly contrasting with the Sensex’s positive 8.95% return over the same period. Profitability has also deteriorated, with profits falling by 60.3% in the last year.

The company’s long-term growth has been subdued, with a compound annual growth rate (CAGR) of operating profits at -23.63% over the last five years. Return on equity (ROE) averages a mere 0.88%, indicating limited profitability relative to shareholders’ funds. Return on capital employed (ROCE) stands at 0.1%, further underscoring the company’s constrained efficiency in generating returns from its capital base.

Debt servicing capacity remains a concern, with a Debt to EBITDA ratio of -1.00 times, reflecting a high leverage position relative to earnings before interest, taxes, depreciation, and amortisation. The enterprise value to capital employed ratio of 0.9 suggests the stock is valued expensively relative to the capital it employs, although it trades at a discount compared to peers’ historical valuations.

Rating and Market Capitalisation Insights

MarketsMOJO assigns Evexia Lifecare a Mojo Score of 17.0, categorising it as a Strong Sell. This rating was upgraded from Sell to Strong Sell on 28 Apr 2025, reflecting deteriorating fundamentals and market sentiment. The company’s market capitalisation grade is 4, indicating a relatively small market cap within its sector.

Despite the stock’s discounted valuation relative to peers, the combination of weak profitability, declining earnings, and high leverage weighs heavily on its rating. The stock’s underperformance extends beyond the last year, with returns lagging the BSE500 index over the past three years, one year, and three months.

Shareholding Pattern and Sector Position

Evexia Lifecare operates within the edible oil industry and sector, where competitive pressures and commodity price fluctuations can impact margins. The majority of the company’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics.

The stock’s recent performance and valuation metrics suggest that it remains under pressure relative to sector peers, with limited signs of recovery in the near term based on current data.

Summary of Performance Trends

Evexia Lifecare’s stock has experienced a sustained decline over the past year, with a 42.97% loss in value. This contrasts with the broader market’s positive returns, highlighting the stock’s relative underperformance. Profit declines of over 60% in the last year further compound concerns about the company’s financial health.

The company’s valuation metrics, including a low ROCE and high debt ratio, suggest challenges in generating returns and managing financial obligations effectively. The stock’s trading below all major moving averages reinforces the prevailing negative momentum.

While the stock is trading at a discount compared to peers’ historical valuations, the underlying financial indicators and market performance have contributed to its current 52-week low of Rs.1.48.

Market and Sector Overview

The edible oil sector continues to face headwinds from fluctuating raw material costs and competitive pressures. Evexia Lifecare’s performance must be viewed within this broader context, where sector peers may also be experiencing volatility. However, the company’s specific financial metrics and stock performance indicate a more pronounced decline relative to the sector average.

Market-wide declines across all capitalisation segments, particularly among large caps, have contributed to a challenging environment for stocks like Evexia Lifecare. The Nifty’s recent drop of 1.25% and its position below the 50-day moving average reflect a cautious market sentiment.

Conclusion

Evexia Lifecare Ltd’s stock reaching a 52-week low of Rs.1.48 underscores ongoing pressures on the company’s financial and market performance. The combination of declining profits, subdued growth, high leverage, and weak returns on equity and capital employed have weighed on investor confidence and valuation. Trading below all key moving averages and underperforming its sector and broader indices, the stock remains in a challenging position as of 27 Feb 2026.

Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today